Mads Bastrup Israelsen

Mads Bastrup Israelsen is an Associate Professor at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark (SDU), and is affiliated with Odense University Hospital (OUH) and the FLASH - Centre for Liver Research in Odense. His research is focused on hepatology, particularly alcohol-related and metabolic liver diseases.

His primary research interests include Alcohol-Related Liver Disease, Liver Fibrosis, Liver Cirrhosis, Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease, and genetic and metabolic risk factors in liver disease progression. His work integrates clinical research with translational studies to improve diagnosis and treatment.

His recent publications in journals such as The Lancet and The Lancet Gastroenterology & Hepatology reflect a strong trend toward clinical trials, disease classification, and biomarker validation. Key themes include the redefinition of steatotic liver disease nomenclature, assessment of alcohol intake, and evaluation of novel therapeutics like rifaximin-α.

His work has been featured in 7 press/media contributions, including coverage in news outlets and clinical guidelines, indicating significant impact beyond academia.

He has supervised at least 2 academic works, contributing to the training of future researchers in hepatology. Although specific grants are not listed, his leadership in multi-center trials like GALA-RIF and involvement in consortia (GALAXY, MicrobLiver) suggest active grant funding and collaborative research.

He is a core member of the FLASH - Centre for Liver Research (Odense), a multidisciplinary team focused on advancing liver disease understanding and treatment through clinical and translational research.